Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Non-small Cell Carcinoma × binimetinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 8 Melanoma 7 Lung Neoplasms 5 Colorectal Neoplasms 4 Triple Negative Breast Neoplasms 3 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Colonic Neoplasms 2 Thyroid Neoplasms 1 Spinocerebellar Degenerations 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Non-small Cell Carcinoma 1 Neurofibromatosis 1 1 Neoplasms 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia 1 Hereditary Sensory and Autonomic Neuropathies 1 Glioma 1 Gastrointestinal Stromal Tumors 1 Fallopian Tube Neoplasms 1 Disease Progression 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma 1 Brain Neoplasms 1 Brain Diseases 1 Blast Crisis 1 Biliary Tract Neoplasms 1

Interventions

pembrolizumab 1 binimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03991819 2025-12-05

BiniPembro

University Health Network, Toronto

Phase 1 Recruiting

Non-small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡